Clinical implications of differential procoagulant toxicity of the palearctic viperid genus Macrovipera, and the relative neutralization efficacy of antivenoms and enzyme inhibitors
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 340, 77-88
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council
This publication has 81 references indexed in Scilit:
- Incidence of Snake Bites in Kashan, Iran During an Eight Year Period (2004-2011)Archives of Trauma Research, 2012
- Preclinical Evaluation of Caprylic Acid-Fractionated IgG Antivenom for the Treatment of Taipan (Oxyuranus scutellatus) Envenoming in Papua New GuineaPLOS Neglected Tropical Diseases, 2011
- Cross neutralization of Hypnale hypnale (hump-nosed pit viper) venom by polyvalent and monovalent Malayan pit viper antivenoms in vitro and in a rodent modelActa Tropica, 2011
- Three Continents Claiming an Archipelago: The Evolution of Aegean’s Herpetofaunal DiversityDiversity, 2010
- Recent advances in phylogeny and taxonomy of Near and Middle Eastern Vipers – an updateZooKeys, 2009
- A nesting of vipers: Phylogeny and historical biogeography of the Viperidae (Squamata: Serpentes)Molecular Phylogenetics and Evolution, 2008
- Comparison of Active Venom Components between Eastern Brown Snakes Collected from South Australia and QueenslandEcotoxicology, 2005
- Proteases from Vipera lebetina Venom Affecting Coagulation and FibrinolysisPathophysiology of Haemostasis and Thrombosis, 2001
- In vitro coagulant properties of venoms from Australian snakesToxicon, 1982
- Activation of prothrombin with Taipan snake venomThrombosis Research, 1972